Explore our company news, announcements and updates
June 17, 2026
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
June 4, 2026
New Research from MSD Animal Health Reveals “Hidden” Parasitic Infections Cost Global Dairy Industry Billions Each Year
March 18, 2026
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from MSD Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
February 25, 2026
FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from MSD Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis
February 24, 2026
MSD Animal Health Wins 2025 S&P Global Award in Best Product Companion Animal and Best Product Food Animal Categories for NUMELVI and INNOVAX® ND-IBD-ILT, Respectively
February 9, 2026
MSD Animal Health and FVE Reward 34 Veterinary Students from Across Europe
December 4, 2025
FDA Conditionally Approves MSD Animal Health’s EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
November 4, 2025
Mexico’s SADER Approves MSD Animal Health’s EXZOLT® 5% Pour-On (Fluralaner 50 mg/mL) for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (Myiasis)
October 23, 2025
New Data from MSD Animal Health Demonstrates that Intranasal Vaccination Against Bovine Coronavirus with BOVILIS® NASALGEN®-C (Lyophilisate and Solvent for Suspension for Cattle) Significantly Improves Production in Veal Calves
September 26, 2025
MSD Animal Health Presents New Data Demonstrating the Safety, Efficacy and Quick Onset of Injectable Formulation of BRAVECTO® (fluralaner) at World Small Animal Veterinary Association Congress
September 25, 2025